Clinical Trial Update: Autologous Heterotopic Fresh Ovarian Graft in Woman With LACC Eligible for Pelvic Radiotherapy Treatment. [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating autologous heterotopic fresh ovarian grafting in women with locally advanced cervical cancer eligible for pelvic radiotherapy, aiming…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Premature Ovarian Failure

Snippet

Sponsor: MARILIA ALBANEZI BERTOLAZZI | Conditions: Locally Advanced Cervical Carcinoma, Premature Ovarian Failure | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING